These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22242398)

  • 1. [Research advances in the treatment of hyperhomocysteinemia].
    Cheng S; Feng J; Wang X
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):329-34. PubMed ID: 22242398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
    Kang SS; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homocysteine and hyperhomocysteinemia].
    Laskowska-Klita T
    Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
    Boxer AL; Kramer JH; Johnston K; Goldman J; Finley R; Miller BL
    Neurology; 2005 Apr; 64(8):1431-4. PubMed ID: 15851736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency.
    Schwahn BC; Chen Z; Laryea MD; Wendel U; Lussier-Cacan S; Genest J; Mar MH; Zeisel SH; Castro C; Garrow T; Rozen R
    FASEB J; 2003 Mar; 17(3):512-4. PubMed ID: 12551843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methionine-homocysteine cycle and its effects on cognitive diseases.
    Miller AL
    Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting plasma homocysteine levels are increased in young patients with acute myocardial infarction from Western India.
    Ghosh K; Khare A; Shetty S
    Indian Heart J; 2007; 59(3):242-5. PubMed ID: 19124933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of betaine in the treatment of elevated homocysteine.
    Lawson-Yuen A; Levy HL
    Mol Genet Metab; 2006 Jul; 88(3):201-7. PubMed ID: 16545978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H
    Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperhomocysteinemia and kidney diseases].
    Zhou YF; Guan YF
    Sheng Li Xue Bao; 2018 Dec; 70(6):607-611. PubMed ID: 30560269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.